Detalhe da pesquisa
1.
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort.
Ann Rheum Dis
; 2024 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38373843
2.
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
Ann Rheum Dis
; 83(1): 15-29, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827694
3.
Phenotypes in antiphospholipid syndrome: A hierarchical cluster analysis based on two independent databases.
J Autoimmun
; 144: 103173, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38330544
4.
What we know and what we don't know about catastrophic antiphospholipid syndrome.
Rheumatology (Oxford)
; 63(SI): SI46-SI53, 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320593
5.
Risk of Diabetes Mellitus in systemic lupus erythematosus: systematic review and meta-analysis.
Rheumatology (Oxford)
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552312
6.
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.
Rheumatology (Oxford)
; 63(3): 772-779, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307082
7.
Factors associated with early hydroxychloroquine-induced retinal toxicity in patients with systemic lupus erythematosus.
Graefes Arch Clin Exp Ophthalmol
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38578332
8.
Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study.
Lab Invest
; 103(6): 100147, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37044248
9.
2023 ACR/EULAR antiphospholipid syndrome classification criteria.
Ann Rheum Dis
; 82(10): 1258-1270, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37640450
10.
The adjusted Global Anti-Phospholipid Syndrome Score as predictor of damage accrual measured by Damage Index for APS: a longitudinal study.
Rheumatology (Oxford)
; 62(6): 2211-2219, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282534
11.
Preclinical ocular changes in systemic lupus erythematosus patients by optical coherence tomography.
Rheumatology (Oxford)
; 62(7): 2475-2482, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331348
12.
Predictive value of the adjusted Global Anti-Phospholipid Syndrome Score on clinical recurrence in APS patients: a longitudinal study.
Rheumatology (Oxford)
; 62(4): 1576-1585, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35997555
13.
Organ damage is a major determinant of work productivity impairment in Behçet's Syndrome: a post-hoc analysis of the BODI validation study.
Rheumatology (Oxford)
; 2023 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092032
14.
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products.
Clin Exp Rheumatol
; 41(3): 543-553, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36916322
15.
Cost-effectiveness analysis of treatments for the first episode of catastrophic antiphospholipid syndrome: A study based on the catastrophic antiphospholipid syndrome registry.
Lupus
; 31(2): 194-201, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35037492
16.
The clinical significance of low complement levels in patients with catastrophic antiphospholipid syndrome: A descriptive analysis of 73 patients from the "Catastrophic antiphospholipid syndrome registry".
Lupus
; 31(10): 1218-1225, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35686348
17.
Why lupus patients discontinue antimalarials in real life: A 50 years-experience from a reference centre.
Lupus
; 31(11): 1344-1354, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35848412
18.
Higher body mass index and disease duration are associated with increased risk of left ventricular diastolic dysfunction in women with systemic lupus erythematosus.
Lupus
; 31(13): 1639-1648, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36123774
19.
Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 Coagulopathy.
Int J Mol Sci
; 23(9)2022 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35563337
20.
A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center.
J Autoimmun
; 117: 102580, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33338707